Skip to main content
. 2019 Aug 9;4:26. doi: 10.1038/s41392-019-0054-9

Fig. 4.

Fig. 4

In vivo antitumor efficacy in 4T1 tumor-bearing Balb/C mice. Free MATT, MATT-LTSLs, and the same volume of saline were injected via the tail vein every 3 days at a MATT dose of 5 mg/kg. a Tumor volume fold change. b Body weight changes. c Tumor weight. The tumor was weighed on day 19 post injection (mean ± SD, n = 6, *p < 0.05)